Shanghai Normal University Meng Xiangzong's research group discovered new plant immunity-inducing small peptides and their receptors
Time of Update: 2021-03-25
kinases RGI4 and RGI5 expressed in Arabidopsis leaves, while the SERK (Somatic Embryogenesis Receptor Kinase) family receptor kinases BAK1 and SERK4 acted as co-receptors. The body, interacts with RGI4/RGI5 to form a receptor protein complex
New advances in the therapeutic hepatitis B vaccine in Nat Nanotech, Zhu Mingzhao group reveal
Time of Update: 2020-07-22
Responsible . . . HBV infection is one of the major public health problems in the world. . Globally, there are about 260 million people living with chronic hepatitis B virus, and nearly 1 million people die each year from chronic
Nat E. The islet MHC-II peptide group reveals the main characteristics of autoimmune peptides.
Time of Update: 2020-07-22
Write an article. Xiao Feifei is a rebuke. The occurrence of autoimmune diseases with gene variation and tissue specificity of the class II main tissue compatibility complex (class II major histocompatibility complex, MHC-II) is strongly coriated
Professor Lu Wei interpreted the results of checkMate-870 research, Navuliu mono-anti-adding Chinese group of four major therapeutic characteristics!
Time of Update: 2020-07-17
Good news! Navuliu monoto-anti240 mg fixed dose, 30 minutein infusion is safe and reliable, eGFR mutation / HBV infection patients also have anti-tumor activity! Expert Introduction Dr. Lu Wei, Ph.D. Tutor, Second-level Professor Shanghai Leader
Nat Rev Neurol: a multi group review of stroke biomarkers and therapeutic targets
Time of Update: 2020-06-19
. Among them, ischemic Stroke is the most common type, accounting for 87% of all strokes. However, there is no biomarker for clinical use, which challenges the early diagnosis and treatment of stroke patients
Kun Pharmaceutical Group Osteoporosis Therapeutics Clinical Trial Application Accepted
Time of Update: 2020-06-01
Innovative clinical application the new drug to the United States Amin company has been listed abroad monoclonal antibody drug tinnomonotada (hereinafter referred to as "tinnomonotada") injection as a imitation target, the development of amino
Research group of Professor Liu Runhui of East China University of science and technology: Study
Time of Update: 2019-12-04
Pseudomonas aeruginosa is a common hospital pathogen
Due to its strong adaptability, inherent antibiotic resistance and easy to produce acquired drug resistance
Yu Zhilin research group of Nankai University: cell microenvironment adaptive peptide nanostructure for tumor treatment
Time of Update: 2019-10-21
Under the guidance of this strategy, the research group constructed a pH responsive CIS trans isomerization regulated pentapeptide assembly, and constructed a tumor microenvironment responsive adaptive nanodrug system (TMAs), which was used to improve drug delivery and enhance photodynamic therapy.
Liu Runhui, Professor of East China University of science and technology research group: the effect
Time of Update: 2019-10-11
Recently, the top journal of the American Chemical Society, titled "impact of antifouling peg layer on the performance of functional peptides in regulatingcell behaviors", reported
Liu Runhui, Professor of East China University of science and technology research group: fast
Time of Update: 2019-05-09
Author: as the main drug to treat microbial infection, Zhang Qiang, a master's student, has been playing an important role in the field of medical and health since it was found
Zhang Wenbin research group of Peking University develops protein stapler enzymes to achieve efficient peptide peptide coupling reaction
Time of Update: 2019-02-10
Recently, Zhang Wenbin's research group of Peking University has developed a unique spy stapler with disordered structure, which realizes the efficient coupling of spy tag and bdtag in and out of cells.
Liu Runhui, Professor of East China University of science and technology research group: α / β
Time of Update: 2018-10-13
Liu Runhui, Professor of East China University of science and technology, has been devoted to the study of host defense peptide analogues.
Wang Mingwei group of Shanghai Institute of medicine, Chinese Academy of Sciences has made new
Time of Update: 2018-06-22
The results showed that glucagon like peptide-1 Different amino acid sites on the receptor regulate the affinity of the ligand and the signal pathway it activates.